EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6.

Speaking at the CherryBrooks AI Conference, in Abuja, Olawumi emphasised NITDA’s commitment to responsible AI deployment, ...

Institutional Class shares of Columbia Select Large Cap Value Fund returned 2.91% for the quarter ending March 31, 2025.

Capital One has agreed to pay $425 million in compensation to its customers who have held a 360 savings account since ...

This investment in a new Smartsheet Regions Australia underscores our dedication to the APJ region and the local data residency needs of our ...

Technical information and data in this news release has been reviewed and approved by Dr. Scott Jobin-Bevans (P.Geo., PGO ...

PFOS, also known as "forever chemicals," are synthetic compounds popular for several commercial applications, like making ...

PFOS, also known as "forever chemicals," are synthetic compounds popular for several commercial applications like making ...

Arati Prabhakar, former Science and Technology Advisor to President Biden and current UC Berkeley Executive Fellow in Applied ...

Dovenmuehle Mortgage, Inc. (DMI), a leading mortgage subservicing company, today announced a partnership with SESLOC Credit ...